Report overview
The global Antiandrogen market was valued at 6887 million in 2024 and is projected to reach US$ 10300 million by 2032, at a CAGR of 6.1% during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Steroidal Antiandrogen segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Antiandrogen include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui, Bayer, Schering-Plough, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Antiandrogen companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Antiandrogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiandrogen. This report contains market size and forecasts of Antiandrogen in global, including the following market information:
Global Antiandrogen market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Antiandrogen companies in 2024 (%)
Total Market by Segment:
Global Antiandrogen market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by Type, 2024 (%)
Steroidal Antiandrogen
Nonsteroidal Antiandrogen
Global Antiandrogen market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by Application, 2024 (%)
Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
Global Antiandrogen market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Antiandrogen market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiandrogen revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Antiandrogen revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiandrogen, market overview.
Chapter 2: Global Antiandrogen market size in revenue.
Chapter 3: Detailed analysis of Antiandrogen company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiandrogen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
